European Commission Approval

RAHWAY, N.J., April 17, 2026 Merck & Co., Inc. announced that the European Commission (EC) has approved ENFLONSIA™ (clesrovimab),...

RAHWAY, N.J., April 2, 2026 Merck (MSD) has secured a major regulatory milestone as the European Commission approves KEYTRUDA®...

March 06, 2026 — Wilmington, Delaware, USA Global biopharmaceutical innovator Incyte has announced that the European Commission has approved...

London, United Kingdom, January 26, 2026 — GSK announced that the European Commission (EC) has approved an expanded indication...

Berlin, Germany – September 19, 2025 — Bayer announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products...

SHANGHAI, China & JERSEY CITY, NJ – September 19, 2025, Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN)...